| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gadolinium | 60 | 2023 | 951 | 10.890 |
Why?
|
| Contrast Media | 81 | 2023 | 5295 | 9.810 |
Why?
|
| Organometallic Compounds | 30 | 2023 | 665 | 5.630 |
Why?
|
| Coordination Complexes | 14 | 2022 | 115 | 5.010 |
Why?
|
| Fibrin | 20 | 2022 | 506 | 4.950 |
Why?
|
| Manganese | 15 | 2023 | 408 | 4.570 |
Why?
|
| Chelating Agents | 20 | 2020 | 380 | 4.230 |
Why?
|
| Magnetic Resonance Imaging | 104 | 2023 | 35342 | 4.120 |
Why?
|
| Molecular Imaging | 15 | 2023 | 831 | 3.470 |
Why?
|
| Molecular Probes | 12 | 2022 | 316 | 3.000 |
Why?
|
| Gadolinium DTPA | 19 | 2023 | 836 | 2.680 |
Why?
|
| Pulmonary Fibrosis | 9 | 2020 | 526 | 2.640 |
Why?
|
| Heterocyclic Compounds, 1-Ring | 9 | 2019 | 65 | 2.500 |
Why?
|
| 2-Aminoadipic Acid | 4 | 2023 | 33 | 2.360 |
Why?
|
| Liver Cirrhosis | 12 | 2023 | 1864 | 2.330 |
Why?
|
| Water | 22 | 2019 | 1388 | 2.290 |
Why?
|
| Positron-Emission Tomography | 27 | 2022 | 6259 | 2.240 |
Why?
|
| Copper Radioisotopes | 7 | 2020 | 86 | 2.030 |
Why?
|
| Fibrosis | 13 | 2023 | 2026 | 2.020 |
Why?
|
| Peptides | 16 | 2020 | 4392 | 1.960 |
Why?
|
| Gallium Radioisotopes | 8 | 2023 | 178 | 1.860 |
Why?
|
| Aldehydes | 3 | 2023 | 167 | 1.840 |
Why?
|
| Serum Albumin | 12 | 2016 | 674 | 1.770 |
Why?
|
| Liver | 14 | 2023 | 7470 | 1.550 |
Why?
|
| Collagen Type I | 6 | 2023 | 592 | 1.530 |
Why?
|
| Collagen | 16 | 2023 | 2684 | 1.530 |
Why?
|
| Molecular Structure | 20 | 2021 | 1907 | 1.340 |
Why?
|
| Thrombosis | 11 | 2021 | 2966 | 1.330 |
Why?
|
| Heterocyclic Compounds | 8 | 2020 | 249 | 1.330 |
Why?
|
| Radiopharmaceuticals | 9 | 2022 | 2658 | 1.290 |
Why?
|
| Albumins | 6 | 2014 | 568 | 1.220 |
Why?
|
| Organic Anion Transporters | 2 | 2023 | 100 | 1.050 |
Why?
|
| Tissue Distribution | 15 | 2023 | 2335 | 1.050 |
Why?
|
| Magnetic Resonance Angiography | 5 | 2017 | 1440 | 1.030 |
Why?
|
| Intracranial Thrombosis | 3 | 2021 | 113 | 0.970 |
Why?
|
| Rats, Wistar | 12 | 2020 | 1902 | 0.950 |
Why?
|
| Animals | 88 | 2023 | 168561 | 0.930 |
Why?
|
| Rats | 26 | 2023 | 24265 | 0.890 |
Why?
|
| Peroxidases | 2 | 2022 | 138 | 0.890 |
Why?
|
| Nephritis, Hereditary | 1 | 2023 | 87 | 0.880 |
Why?
|
| Liposomes | 3 | 2017 | 758 | 0.870 |
Why?
|
| Liver Diseases | 2 | 2020 | 1252 | 0.810 |
Why?
|
| Alanine | 2 | 2015 | 572 | 0.810 |
Why?
|
| Radioisotopes | 4 | 2021 | 499 | 0.800 |
Why?
|
| Disease Models, Animal | 27 | 2023 | 18006 | 0.780 |
Why?
|
| Venous Thrombosis | 3 | 2015 | 1237 | 0.780 |
Why?
|
| Kinetics | 15 | 2018 | 6474 | 0.780 |
Why?
|
| Manganese Compounds | 3 | 2021 | 27 | 0.730 |
Why?
|
| Bleomycin | 6 | 2023 | 499 | 0.710 |
Why?
|
| Chromatography, High Pressure Liquid | 6 | 2017 | 1574 | 0.710 |
Why?
|
| Metalloproteins | 2 | 2013 | 100 | 0.680 |
Why?
|
| Mice | 47 | 2023 | 81045 | 0.680 |
Why?
|
| Yttrium Radioisotopes | 1 | 2019 | 93 | 0.670 |
Why?
|
| Naphthalenesulfonates | 1 | 2017 | 15 | 0.620 |
Why?
|
| Acetates | 1 | 2019 | 312 | 0.610 |
Why?
|
| Peroxidase | 2 | 2018 | 610 | 0.580 |
Why?
|
| Antibiotics, Antineoplastic | 3 | 2017 | 692 | 0.580 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 4 | 2013 | 507 | 0.580 |
Why?
|
| Whole Body Imaging | 2 | 2015 | 280 | 0.560 |
Why?
|
| Thermodynamics | 9 | 2022 | 594 | 0.550 |
Why?
|
| Models, Molecular | 9 | 2017 | 5454 | 0.550 |
Why?
|
| Amines | 1 | 2017 | 278 | 0.530 |
Why?
|
| Indium Radioisotopes | 1 | 2015 | 118 | 0.530 |
Why?
|
| Scleroderma, Systemic | 1 | 2019 | 313 | 0.520 |
Why?
|
| Magnetic Resonance Spectroscopy | 12 | 2022 | 3760 | 0.520 |
Why?
|
| Radiometry | 3 | 2022 | 800 | 0.520 |
Why?
|
| Sulfides | 1 | 2016 | 166 | 0.520 |
Why?
|
| Liver Cirrhosis, Experimental | 1 | 2015 | 32 | 0.520 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 4 | 2023 | 451 | 0.510 |
Why?
|
| Protons | 6 | 2012 | 1126 | 0.510 |
Why?
|
| Half-Life | 4 | 2017 | 658 | 0.500 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2017 | 578 | 0.500 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2016 | 388 | 0.500 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2014 | 53 | 0.490 |
Why?
|
| Lung | 10 | 2023 | 9826 | 0.490 |
Why?
|
| Gastrointestinal Tract | 1 | 2020 | 814 | 0.480 |
Why?
|
| Lung Diseases, Interstitial | 2 | 2020 | 807 | 0.480 |
Why?
|
| Kidney | 6 | 2023 | 7167 | 0.480 |
Why?
|
| Molecular Conformation | 5 | 2020 | 563 | 0.470 |
Why?
|
| Quantum Theory | 1 | 2013 | 70 | 0.470 |
Why?
|
| Central Nervous System | 2 | 2018 | 1354 | 0.470 |
Why?
|
| Doxorubicin | 2 | 2017 | 2215 | 0.460 |
Why?
|
| Liver Neoplasms | 4 | 2023 | 4249 | 0.460 |
Why?
|
| Drug Design | 3 | 2015 | 1078 | 0.440 |
Why?
|
| Protein Binding | 13 | 2020 | 9387 | 0.420 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2023 | 2211 | 0.420 |
Why?
|
| Phenols | 1 | 2016 | 501 | 0.420 |
Why?
|
| Cysteine | 1 | 2016 | 873 | 0.410 |
Why?
|
| Carbon Tetrachloride | 4 | 2017 | 64 | 0.410 |
Why?
|
| Ligands | 7 | 2022 | 3293 | 0.400 |
Why?
|
| Drug Stability | 4 | 2014 | 290 | 0.390 |
Why?
|
| Bone Neoplasms | 3 | 2021 | 2522 | 0.390 |
Why?
|
| Intestines | 1 | 2020 | 1923 | 0.390 |
Why?
|
| Staining and Labeling | 3 | 2020 | 1099 | 0.380 |
Why?
|
| Indoles | 1 | 2019 | 1834 | 0.370 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 2017 | 2552 | 0.370 |
Why?
|
| Image Processing, Computer-Assisted | 8 | 2021 | 8925 | 0.350 |
Why?
|
| Bacteriophages | 1 | 2012 | 354 | 0.330 |
Why?
|
| Pneumonia | 2 | 2020 | 2117 | 0.320 |
Why?
|
| Oxidation-Reduction | 5 | 2020 | 2187 | 0.310 |
Why?
|
| Sirolimus | 1 | 2015 | 1562 | 0.310 |
Why?
|
| Lung Injury | 2 | 2023 | 436 | 0.310 |
Why?
|
| Lanthanoid Series Elements | 1 | 2007 | 16 | 0.300 |
Why?
|
| Ferric Compounds | 3 | 2021 | 374 | 0.300 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 3 | 2018 | 1107 | 0.290 |
Why?
|
| Myocytes, Cardiac | 3 | 2011 | 1636 | 0.290 |
Why?
|
| Diethylnitrosamine | 3 | 2016 | 38 | 0.290 |
Why?
|
| Chemical Phenomena | 3 | 2016 | 517 | 0.280 |
Why?
|
| Myocardial Infarction | 6 | 2023 | 11690 | 0.280 |
Why?
|
| Pancreatic Neoplasms | 3 | 2020 | 5249 | 0.280 |
Why?
|
| Spectrophotometry | 1 | 2006 | 313 | 0.280 |
Why?
|
| Inflammation | 6 | 2021 | 10578 | 0.270 |
Why?
|
| Structure-Activity Relationship | 6 | 2020 | 3133 | 0.270 |
Why?
|
| Disease Progression | 4 | 2017 | 13256 | 0.270 |
Why?
|
| Humans | 70 | 2023 | 742088 | 0.270 |
Why?
|
| Temperature | 5 | 2013 | 2207 | 0.270 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2012 | 964 | 0.270 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2020 | 2410 | 0.270 |
Why?
|
| Random Allocation | 4 | 2020 | 2425 | 0.260 |
Why?
|
| Fluorouracil | 3 | 2020 | 1615 | 0.260 |
Why?
|
| Helix-Turn-Helix Motifs | 1 | 2003 | 13 | 0.240 |
Why?
|
| Male | 41 | 2022 | 349538 | 0.240 |
Why?
|
| Myocardium | 3 | 2018 | 4775 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 11 | 2021 | 21821 | 0.240 |
Why?
|
| Macrophages | 3 | 2022 | 5655 | 0.240 |
Why?
|
| Lysine | 1 | 2008 | 1008 | 0.240 |
Why?
|
| Oligopeptides | 1 | 2009 | 1176 | 0.230 |
Why?
|
| Amino Acid Sequence | 6 | 2014 | 13814 | 0.230 |
Why?
|
| Diamines | 2 | 2021 | 59 | 0.220 |
Why?
|
| Picolinic Acids | 2 | 2021 | 53 | 0.220 |
Why?
|
| Hydrogen | 1 | 2003 | 164 | 0.220 |
Why?
|
| Image Enhancement | 4 | 2019 | 2921 | 0.220 |
Why?
|
| Monocytes | 1 | 2012 | 2593 | 0.220 |
Why?
|
| Stomach Neoplasms | 2 | 2022 | 1327 | 0.220 |
Why?
|
| Coronary Stenosis | 1 | 2009 | 834 | 0.220 |
Why?
|
| Cardiovascular System | 1 | 2010 | 827 | 0.210 |
Why?
|
| Molecular Sequence Data | 6 | 2014 | 18112 | 0.210 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 2370 | 0.210 |
Why?
|
| Sarcosine | 1 | 2001 | 15 | 0.210 |
Why?
|
| Dysprosium | 1 | 2001 | 25 | 0.210 |
Why?
|
| Proteins | 4 | 2015 | 6096 | 0.210 |
Why?
|
| Models, Biological | 1 | 2019 | 9581 | 0.210 |
Why?
|
| Carboxylesterase | 1 | 2021 | 31 | 0.210 |
Why?
|
| Models, Chemical | 4 | 2009 | 626 | 0.210 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2017 | 8300 | 0.210 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2021 | 60 | 0.200 |
Why?
|
| Nanoparticles | 3 | 2023 | 1902 | 0.200 |
Why?
|
| Magnetite Nanoparticles | 1 | 2023 | 322 | 0.190 |
Why?
|
| Aza Compounds | 1 | 2020 | 32 | 0.190 |
Why?
|
| Hydrazines | 1 | 2022 | 220 | 0.190 |
Why?
|
| Organophosphorus Compounds | 1 | 2001 | 215 | 0.190 |
Why?
|
| Biopsy, Needle | 2 | 2016 | 1640 | 0.190 |
Why?
|
| Macrocyclic Compounds | 1 | 2020 | 72 | 0.190 |
Why?
|
| Stem Cell Transplantation | 1 | 2009 | 1618 | 0.190 |
Why?
|
| Schistosomiasis mansoni | 1 | 2021 | 85 | 0.190 |
Why?
|
| Chalcones | 1 | 2020 | 28 | 0.180 |
Why?
|
| Magnetics | 2 | 2018 | 609 | 0.180 |
Why?
|
| Leucovorin | 2 | 2020 | 624 | 0.180 |
Why?
|
| Propionates | 1 | 2020 | 168 | 0.180 |
Why?
|
| Europium | 2 | 2014 | 13 | 0.170 |
Why?
|
| Rabbits | 5 | 2021 | 4886 | 0.170 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2020 | 1631 | 0.170 |
Why?
|
| Phosphates | 1 | 2023 | 786 | 0.170 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2022 | 2013 | 0.170 |
Why?
|
| Aorta, Abdominal | 2 | 2021 | 645 | 0.160 |
Why?
|
| Dextrans | 1 | 2020 | 592 | 0.160 |
Why?
|
| Ferrosoferric Oxide | 1 | 2020 | 360 | 0.160 |
Why?
|
| Isotope Labeling | 1 | 2020 | 414 | 0.160 |
Why?
|
| Feasibility Studies | 4 | 2012 | 5062 | 0.150 |
Why?
|
| Atrial Appendage | 1 | 2021 | 282 | 0.150 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2018 | 191 | 0.150 |
Why?
|
| Swine | 4 | 2020 | 5934 | 0.150 |
Why?
|
| Ligation | 2 | 2015 | 453 | 0.150 |
Why?
|
| Aneurysm | 1 | 2020 | 339 | 0.150 |
Why?
|
| Mass Spectrometry | 2 | 2017 | 2203 | 0.150 |
Why?
|
| Ureteral Obstruction | 1 | 2019 | 293 | 0.150 |
Why?
|
| Bile Ducts | 2 | 2015 | 284 | 0.140 |
Why?
|
| Hydrogen Bonding | 1 | 2017 | 293 | 0.140 |
Why?
|
| Limit of Detection | 1 | 2017 | 264 | 0.140 |
Why?
|
| Dendrimers | 2 | 2014 | 68 | 0.140 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2022 | 834 | 0.140 |
Why?
|
| ROC Curve | 2 | 2015 | 3528 | 0.140 |
Why?
|
| Parathyroid Hormone | 1 | 2023 | 1801 | 0.140 |
Why?
|
| Hydrolysis | 1 | 2017 | 682 | 0.140 |
Why?
|
| Radiation Injuries | 1 | 2023 | 1178 | 0.140 |
Why?
|
| Sensitivity and Specificity | 6 | 2022 | 14720 | 0.140 |
Why?
|
| Matrix Metalloproteinases | 1 | 2018 | 391 | 0.140 |
Why?
|
| Heart | 2 | 2020 | 4462 | 0.140 |
Why?
|
| Papio | 1 | 2017 | 656 | 0.140 |
Why?
|
| Bronchoscopy | 1 | 2021 | 860 | 0.140 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2018 | 256 | 0.140 |
Why?
|
| Peritoneal Neoplasms | 1 | 2022 | 663 | 0.130 |
Why?
|
| Brain Ischemia | 1 | 2010 | 3258 | 0.130 |
Why?
|
| Renal Artery | 1 | 2017 | 398 | 0.130 |
Why?
|
| Stem Cell Niche | 1 | 2018 | 342 | 0.130 |
Why?
|
| Fluorescent Dyes | 2 | 2015 | 1915 | 0.130 |
Why?
|
| Serotonin | 1 | 2019 | 1024 | 0.130 |
Why?
|
| Mice, Inbred A | 1 | 2014 | 248 | 0.130 |
Why?
|
| Chemistry, Physical | 2 | 2006 | 156 | 0.120 |
Why?
|
| Luminescence | 1 | 2015 | 137 | 0.120 |
Why?
|
| Edetic Acid | 1 | 2014 | 277 | 0.120 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2019 | 867 | 0.120 |
Why?
|
| Integrins | 1 | 2018 | 845 | 0.120 |
Why?
|
| Gastroenterology | 1 | 2020 | 534 | 0.120 |
Why?
|
| Ultrafiltration | 2 | 2005 | 57 | 0.120 |
Why?
|
| Mice, Inbred Strains | 2 | 2014 | 1827 | 0.120 |
Why?
|
| Steroids | 1 | 2019 | 931 | 0.120 |
Why?
|
| Fatty Acids | 1 | 2001 | 1806 | 0.120 |
Why?
|
| Lasers | 1 | 2018 | 952 | 0.110 |
Why?
|
| Pancreas | 1 | 2020 | 1684 | 0.110 |
Why?
|
| Capillary Permeability | 1 | 2017 | 798 | 0.110 |
Why?
|
| Molecular Probe Techniques | 1 | 2013 | 119 | 0.110 |
Why?
|
| Rotation | 1 | 2015 | 523 | 0.110 |
Why?
|
| Hyperalgesia | 1 | 2017 | 502 | 0.110 |
Why?
|
| Ibuprofen | 1 | 2014 | 235 | 0.110 |
Why?
|
| Solvents | 2 | 2020 | 302 | 0.110 |
Why?
|
| Hydroxyproline | 1 | 2012 | 114 | 0.110 |
Why?
|
| Abdomen | 1 | 2018 | 1107 | 0.110 |
Why?
|
| Suspensions | 1 | 2012 | 64 | 0.110 |
Why?
|
| Metabolic Clearance Rate | 2 | 2009 | 379 | 0.110 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 11363 | 0.110 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2012 | 225 | 0.100 |
Why?
|
| Binding Sites | 4 | 2011 | 6115 | 0.100 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2013 | 198 | 0.100 |
Why?
|
| Prospective Studies | 6 | 2023 | 53187 | 0.100 |
Why?
|
| Cell Line, Tumor | 5 | 2022 | 16665 | 0.100 |
Why?
|
| Pentetic Acid | 2 | 2009 | 213 | 0.100 |
Why?
|
| Biosensing Techniques | 1 | 2018 | 668 | 0.100 |
Why?
|
| Iodine Radioisotopes | 1 | 2015 | 1030 | 0.100 |
Why?
|
| Cisplatin | 1 | 2018 | 1637 | 0.100 |
Why?
|
| Cerebrovascular Disorders | 1 | 2018 | 1499 | 0.100 |
Why?
|
| Lung Diseases | 1 | 2021 | 1884 | 0.100 |
Why?
|
| Crystallography, X-Ray | 2 | 2013 | 2014 | 0.100 |
Why?
|
| DNA | 2 | 2011 | 7289 | 0.100 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2015 | 793 | 0.100 |
Why?
|
| Solutions | 3 | 2007 | 426 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2018 | 1402 | 0.090 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2008 | 1372 | 0.090 |
Why?
|
| Iron | 1 | 2019 | 1773 | 0.090 |
Why?
|
| Glutathione | 1 | 2013 | 586 | 0.090 |
Why?
|
| Fluorine | 1 | 2010 | 83 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2016 | 6365 | 0.090 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2021 | 1499 | 0.090 |
Why?
|
| Tyrosine | 1 | 2014 | 1460 | 0.090 |
Why?
|
| Brain Chemistry | 1 | 2013 | 981 | 0.090 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 20774 | 0.090 |
Why?
|
| Female | 23 | 2023 | 379592 | 0.090 |
Why?
|
| Nephrogenic Fibrosing Dermopathy | 1 | 2009 | 42 | 0.090 |
Why?
|
| Vascular Diseases | 1 | 2018 | 1155 | 0.090 |
Why?
|
| Aorta | 1 | 2017 | 2057 | 0.090 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 730 | 0.090 |
Why?
|
| Neoadjuvant Therapy | 1 | 2020 | 2721 | 0.090 |
Why?
|
| Carbocyanines | 1 | 2009 | 174 | 0.090 |
Why?
|
| Tomography, Optical Coherence | 1 | 2021 | 2637 | 0.080 |
Why?
|
| Motion | 1 | 2013 | 797 | 0.080 |
Why?
|
| Reproducibility of Results | 3 | 2017 | 19862 | 0.080 |
Why?
|
| Biphenyl Compounds | 1 | 2013 | 914 | 0.080 |
Why?
|
| Heart Diseases | 1 | 2021 | 2789 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 4455 | 0.080 |
Why?
|
| Bone Marrow | 1 | 2018 | 2941 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2019 | 2145 | 0.080 |
Why?
|
| Organ Specificity | 2 | 2009 | 2003 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2021 | 20086 | 0.080 |
Why?
|
| Mice, Nude | 3 | 2022 | 3689 | 0.080 |
Why?
|
| Sus scrofa | 1 | 2009 | 437 | 0.080 |
Why?
|
| Polyamines | 1 | 2008 | 120 | 0.080 |
Why?
|
| Stroke | 1 | 2010 | 9963 | 0.070 |
Why?
|
| Multiple Sclerosis | 1 | 2022 | 3076 | 0.070 |
Why?
|
| Quinazolines | 1 | 2014 | 1355 | 0.070 |
Why?
|
| Drug Approval | 1 | 2014 | 740 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 15530 | 0.070 |
Why?
|
| Linear Models | 1 | 2017 | 5948 | 0.070 |
Why?
|
| Extracellular Space | 1 | 2009 | 594 | 0.070 |
Why?
|
| Deuterium Oxide | 1 | 2006 | 34 | 0.070 |
Why?
|
| Potentiometry | 2 | 2007 | 10 | 0.070 |
Why?
|
| Stereoisomerism | 1 | 2007 | 625 | 0.070 |
Why?
|
| Time Factors | 5 | 2020 | 40054 | 0.070 |
Why?
|
| Artifacts | 2 | 2020 | 1903 | 0.070 |
Why?
|
| Methanol | 1 | 2006 | 85 | 0.070 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 627 | 0.070 |
Why?
|
| Guinea Pigs | 1 | 2008 | 1386 | 0.070 |
Why?
|
| Acute Disease | 2 | 2013 | 7141 | 0.070 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2005 | 165 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2021 | 3306 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 2 | 2011 | 2699 | 0.070 |
Why?
|
| Bone and Bones | 1 | 2016 | 2575 | 0.070 |
Why?
|
| Metal Nanoparticles | 1 | 2010 | 403 | 0.070 |
Why?
|
| Electrons | 1 | 2006 | 268 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2020 | 9144 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 3 | 2019 | 6382 | 0.060 |
Why?
|
| Fibrinogen | 1 | 2008 | 894 | 0.060 |
Why?
|
| Chromatography, Gel | 2 | 2020 | 668 | 0.060 |
Why?
|
| Brain | 2 | 2023 | 26343 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 13655 | 0.060 |
Why?
|
| Fluorocarbons | 1 | 2009 | 452 | 0.060 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 2382 | 0.060 |
Why?
|
| Algorithms | 4 | 2015 | 13853 | 0.060 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2006 | 689 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2008 | 1802 | 0.060 |
Why?
|
| Organic Anion Transporters, Sodium-Independent | 1 | 2023 | 24 | 0.060 |
Why?
|
| Carotid Artery Diseases | 1 | 2010 | 882 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 4933 | 0.060 |
Why?
|
| Coronary Circulation | 1 | 2009 | 1572 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12242 | 0.060 |
Why?
|
| Phantoms, Imaging | 2 | 2018 | 2466 | 0.050 |
Why?
|
| Carotid Stenosis | 1 | 2010 | 854 | 0.050 |
Why?
|
| Lactate Dehydrogenases | 1 | 2022 | 26 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 462 | 0.050 |
Why?
|
| Dansyl Compounds | 1 | 2001 | 20 | 0.050 |
Why?
|
| Cell Proliferation | 3 | 2018 | 10472 | 0.050 |
Why?
|
| Pain | 1 | 2017 | 4961 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 9185 | 0.050 |
Why?
|
| Diet | 1 | 2020 | 7923 | 0.050 |
Why?
|
| Hexokinase | 1 | 2022 | 125 | 0.050 |
Why?
|
| Losartan | 1 | 2023 | 298 | 0.050 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2022 | 192 | 0.050 |
Why?
|
| Infarction | 1 | 2023 | 243 | 0.050 |
Why?
|
| Receptor, erbB-3 | 1 | 2022 | 142 | 0.050 |
Why?
|
| Species Specificity | 1 | 2006 | 2479 | 0.050 |
Why?
|
| Smad Proteins | 1 | 2021 | 162 | 0.050 |
Why?
|
| Lactates | 1 | 2022 | 432 | 0.050 |
Why?
|
| Azurin | 1 | 2020 | 4 | 0.050 |
Why?
|
| Pyruvic Acid | 1 | 2022 | 200 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11472 | 0.050 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 15056 | 0.050 |
Why?
|
| Dogs | 1 | 2006 | 3910 | 0.050 |
Why?
|
| Thrombolytic Therapy | 1 | 2010 | 2161 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2002 | 1159 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2014 | 5019 | 0.050 |
Why?
|
| Transition Elements | 1 | 2020 | 18 | 0.050 |
Why?
|
| Electrochemical Techniques | 1 | 2020 | 98 | 0.050 |
Why?
|
| Schistosoma mansoni | 1 | 2021 | 149 | 0.050 |
Why?
|
| Lutetium | 1 | 2020 | 32 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 3557 | 0.050 |
Why?
|
| NIH 3T3 Cells | 1 | 2021 | 677 | 0.040 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 314 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2008 | 10943 | 0.040 |
Why?
|
| Adenocarcinoma | 2 | 2018 | 6347 | 0.040 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2021 | 482 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2006 | 2372 | 0.040 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2020 | 341 | 0.040 |
Why?
|
| Cell Survival | 1 | 2009 | 5872 | 0.040 |
Why?
|
| NAD | 1 | 2023 | 594 | 0.040 |
Why?
|
| Fluorescence | 1 | 2001 | 751 | 0.040 |
Why?
|
| Glycolysis | 1 | 2023 | 825 | 0.040 |
Why?
|
| Mice, Inbred mdx | 1 | 2018 | 90 | 0.040 |
Why?
|
| Radiography | 1 | 2010 | 7010 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2021 | 675 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 9274 | 0.040 |
Why?
|
| Cell Death | 2 | 2016 | 1695 | 0.040 |
Why?
|
| Copper | 1 | 2001 | 366 | 0.040 |
Why?
|
| Swine, Miniature | 1 | 2020 | 961 | 0.040 |
Why?
|
| Transplantation, Heterotopic | 1 | 2018 | 175 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2020 | 407 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2020 | 1420 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2013 | 6669 | 0.040 |
Why?
|
| Pyrones | 1 | 1997 | 37 | 0.040 |
Why?
|
| Standard of Care | 1 | 2022 | 562 | 0.040 |
Why?
|
| Skin Absorption | 1 | 2018 | 93 | 0.040 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2018 | 111 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2022 | 849 | 0.040 |
Why?
|
| Mammals | 1 | 2023 | 1135 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2023 | 1028 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2021 | 952 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2023 | 879 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 1213 | 0.040 |
Why?
|
| Buffers | 1 | 2016 | 147 | 0.040 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2016 | 94 | 0.040 |
Why?
|
| Scattering, Small Angle | 1 | 2016 | 59 | 0.040 |
Why?
|
| Diffusion of Innovation | 1 | 2021 | 725 | 0.030 |
Why?
|
| Stem Cells | 1 | 2009 | 3563 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2021 | 2723 | 0.030 |
Why?
|
| Organoplatinum Compounds | 1 | 2017 | 408 | 0.030 |
Why?
|
| X-Ray Diffraction | 1 | 2016 | 420 | 0.030 |
Why?
|
| Aged | 8 | 2021 | 162944 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 2018 | 711 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2021 | 1692 | 0.030 |
Why?
|
| Pancreatectomy | 1 | 2020 | 802 | 0.030 |
Why?
|
| Deferoxamine | 1 | 2015 | 151 | 0.030 |
Why?
|
| Middle Aged | 8 | 2022 | 213127 | 0.030 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2016 | 282 | 0.030 |
Why?
|
| Zirconium | 1 | 2015 | 100 | 0.030 |
Why?
|
| Durapatite | 1 | 2016 | 161 | 0.030 |
Why?
|
| Serum | 1 | 2016 | 212 | 0.030 |
Why?
|
| Boron Compounds | 1 | 2015 | 178 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 2077 | 0.030 |
Why?
|
| Prognosis | 3 | 2021 | 29010 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 1740 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 2006 | 0.030 |
Why?
|
| Apoptosis | 1 | 2010 | 9715 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 2502 | 0.030 |
Why?
|
| Hepatic Stellate Cells | 1 | 2014 | 109 | 0.030 |
Why?
|
| Respiration | 1 | 2020 | 1645 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2018 | 1961 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2022 | 2455 | 0.030 |
Why?
|
| Phenotype | 2 | 2021 | 16331 | 0.030 |
Why?
|
| Homeostasis | 1 | 2023 | 3335 | 0.030 |
Why?
|
| Pancreatitis | 1 | 2019 | 1090 | 0.030 |
Why?
|
| Nanostructures | 1 | 2016 | 550 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2021 | 4143 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2013 | 413 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2019 | 21719 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 2211 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2016 | 1181 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2017 | 19223 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 6891 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 1889 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 2915 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 2187 | 0.020 |
Why?
|
| Titrimetry | 1 | 2007 | 36 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 6483 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 7721 | 0.020 |
Why?
|
| Molecular Biology | 1 | 2011 | 595 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2019 | 3444 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2017 | 3418 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2020 | 10248 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2014 | 1209 | 0.020 |
Why?
|
| Necrosis | 1 | 2011 | 1643 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 4029 | 0.020 |
Why?
|
| Nitrogen | 1 | 2007 | 343 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2021 | 6540 | 0.020 |
Why?
|
| Amides | 1 | 2008 | 458 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2015 | 2410 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 5522 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 1997 | 2866 | 0.020 |
Why?
|
| Endarterectomy, Carotid | 1 | 2010 | 546 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 15994 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2020 | 3428 | 0.020 |
Why?
|
| Skin | 1 | 2018 | 4353 | 0.020 |
Why?
|
| Serine | 1 | 2007 | 828 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1997 | 6249 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2007 | 1727 | 0.010 |
Why?
|
| Adult | 4 | 2022 | 213712 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2021 | 77098 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2017 | 14554 | 0.010 |
Why?
|
| Quality Control | 1 | 2004 | 841 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 12071 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17400 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39004 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2021 | 23387 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 2217 | 0.010 |
Why?
|
| Young Adult | 2 | 2018 | 56350 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2008 | 6440 | 0.010 |
Why?
|
| Mutation | 1 | 2018 | 29717 | 0.010 |
Why?
|
| United States | 1 | 2021 | 69693 | 0.010 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1997 | 1121 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2004 | 6191 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 85649 | 0.010 |
Why?
|
| Child | 1 | 2017 | 77478 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 57683 | 0.000 |
Why?
|